by The global microRNA market size was valued at USD 1,252.80 million in 2022 and is projected to reach USD 7,757.01 million by 2032, growing at a CAGR of 20% from 2023 to 2032, According to Precedence Research.
The global microRNA market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.
Download The Sample Copy For Better Understanding@ https://www.precedenceresearch.com/sample/3023
MicroRNA Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 1,503.36 Million |
| Market Size by 2032 | USD 7,757.01 Million |
| Growth Rate from 2023 to 2032 | CAGR of 20% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Products, By Services, By Application, and By End Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Sequencing Reagents Market Size To Rake USD 13.43 Bn By 2032
Benefits of this market
- This study analyses the market size and share for microRNA along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
- In order to compare the financial capabilities of the microRNA market in the present, a quantitative analysis is done of the market from 2023 to 2032.
- It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
- It is important to understand the most profitable trends in the microRNA market in order to gain an advantage in the market.
- A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
- The report also includes the market share for microRNA for several significant vendors as well as the latest developments in the market.
Leading players of the global microRNA market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global microRNA market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global microRNA market. It also provides useful recommendations for new as well as established players of the global microRNA market.
The major players in the market
- Merck KGaA
- QIAGEN
- Thermo Fisher Scientific Inc.
- Synlogic
- GeneCopoeia, Inc
- Horizon Discovery Ltd.
- New England Biolabs
- Quantabio
- NanoString
- BioGenex
- SeqMatic LLC
- Miltenyi Biotec
- Agilent Technologies, Inc
- Promega Corporation
- Abcam plc
- KANEKA CORPORATION
MicroRNA Market Segmentations:
By Products
- Instruments
- Consumables
By Services
- Service Type
- Isolation & Purification
- miRNA cDNA Synthesis
- Profiling, Localization, & Quantification
- Functional Analysis
- Real Time PCR
- Microarray
- NGS
- Others
- Specimen
- Whole Blood
- Serum
- Plasma
- FFPE
- Fresh Frozen Tissue
- Others
By Application
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
By End Use
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Other end-users
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on MicroRNA Market
5.1. COVID-19 Landscape: MicroRNA Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global MicroRNA Market, By Products
8.1. MicroRNA Market Revenue and Volume Forecast, by Products, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global MicroRNA Market, By Services
9.1. MicroRNA Market Revenue and Volume Forecast, by Services, 2023-2032
9.1.1. Service Type
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Specimen
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global MicroRNA Market, By Application
10.1. MicroRNA Market Revenue and Volume Forecast, by Application, 2023-2032
10.1.1. Cancer
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Infectious Diseases
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Immunological Disorder
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Cardiovascular Disease
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Neurological Disease
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global MicroRNA Market, By End Use
11.1. MicroRNA Market Revenue and Volume Forecast, by End Use, 2023-2032
11.1.1. Biotechnology & Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Academic & Government Research Institutes
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Other end-users
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global MicroRNA Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
Chapter 13. Company Profiles
13.1. Merck KGaA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. QIAGEN
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Synlogic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GeneCopoeia, Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Horizon Discovery Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. New England Biolabs
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Quantabio
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NanoString
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BioGenex
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Key inquiries addressed in the report:
- Investigate the COVID 19 outbreak’s effects.
- Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
